Christopher Barnes
15Patents
4h-index
19Co-inventors
57Inventor score
Filing activity: Aug 21, 2001 → Jun 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7273867B2 | Phenyl derivatives | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7199133B2 | Derivatives of phenoxy-n-′4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors | Chemistry; Metallurgy | 5 | Expired |
| US6943179B2 | Biurethane derivatives | Human Necessities | 4 | Expired |
| US6881722B2 | Saratin for inhibiting platelet adhesion to collagen | Human Necessities | 4 | Expired |
| US11858932B2 | Methods and compositions for treating polycystic ovary syndrome | Human Necessities | 2 | Active |
| US11484531B2 | Methods for treating chronic obstructive pulmonary disease | Human Necessities | 2 | Active |
| US7183277B2 | Carboxylic acid amides | Chemistry; Metallurgy | 2 | Expired |
| US7566789B2 | Benzimidazole derivatives | Chemistry; Metallurgy | 1 | Expired |
| US11642339B2 | Methods of treating symptoms of gastroparesis using velusetrag | Human Necessities | 0 | Active |
| US6849626B2 | Aza-amino acid derivatives (factor Xa inhibitors 15) | Chemistry; Metallurgy | 0 | Expired |
| US12098152B2 | Methods and compositions for treating polycystic ovary syndrome | Human Necessities | 0 | Active |
| US7902223B2 | Phenyl derivatives as factor XA inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12048692B2 | Methods for treating chronic obstructive pulmonary disease | Human Necessities | 0 | Active |
| US12285417B2 | Methods for treating chronic obstructive pulmonary disease | Human Necessities | 0 | Active |
| US7459438B2 | Specific mechanism for inhibiting platelet adhesion to collagen | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.